Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Total Current Liabilities (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) reported Total Current Liabilities of $54.17 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 21.6% from $44.55 million a year earlier and up 16.6% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Total Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals posted Total Current Liabilities of $48.56 million, down 15.6% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • By fiscal year, Total Current Liabilities came in at $57.54 million in FY2024 (-8.4%), $62.79 million in FY2023 (+110.5%), $29.83 million in FY2022 (-17.5%) and $36.17 million in FY2021 (+49.7%).
  • The fiscal Q3 2026 figure ranks as the highest quarterly Total Current Liabilities since fiscal Q4 2024.
  • Year over year, Total Current Liabilities gained in two of the last eight quarters, with an average decline of 8.9%.
  • The high point for year-over-year Total Current Liabilities in five years was fiscal Q3 2023 (growth of 196.0%); the low point was fiscal Q1 2023 (a decline of 39.3%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $46.44 million (Q2 2026), $44.73 million (Q1 2026) and $48.56 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - 54.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.17 Mn
Mar 31, 2026 46.44 Mn
Dec 31, 2025 44.73 Mn
Sep 30, 2025 48.56 Mn
Jun 30, 2025 44.55 Mn
Mar 31, 2025 45.95 Mn
Dec 31, 2024 49.05 Mn
Sep 30, 2024 57.54 Mn
Jun 30, 2024 58.23 Mn
Mar 31, 2024 54.61 Mn
Dec 31, 2023 62.41 Mn
Sep 30, 2023 62.79 Mn
Jun 30, 2023 68.19 Mn
Mar 31, 2023 32.17 Mn
Dec 31, 2022 23.00 Mn
Sep 30, 2022 29.83 Mn
Jun 30, 2022 23.04 Mn
Mar 31, 2022 30.74 Mn
Dec 31, 2021 37.89 Mn
Sep 30, 2021 36.17 Mn
API Access

Enanta Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY